In colorectal cancer, METTL16 plays a key role in promoting glycolytic metabolism and tumor progression by regulating the expression of key glycolytic enzymes, such as SOGA1 and pyruvate dehydrogenase kinase 4 (PDK4). Here, PDK4 is linked to colorectal cancer.